Derek Small - Assembly Biosciences Insider

Assembly Biosciences Inc -- USA Stock  

USD 42.54  0.27  0.64%

Co-Founder, CEO and President and Director

Mr. Derek A. Small is President, Chief Executive Officer, Director of ASSEMBLY BIOSCIENCES, Inc. Mr. Small is a cofounder of Assembly Pharmaceuticals, and has served as Executive Chairman of the company since inception in 2012. From March 2008 to January 2014, Mr. Small served as a founding director, President, and Chief Executive Officer of Naurex, Inc., a privately held biotechnology company. From January 2009 to April 2012, Mr. Small also served as founding director, President, and Chief Executive Officer to Coferon, Inc., a privately held biotechnology company. Each of these companies was founded as portfolio companies of Luson Bioventures, a biotechnology and biopharmaceutical venture creation firm that Mr. Small founded in 2007. Mr. Small continues to serve on the Board of Directors of Naurex, Inc
Age: 38  CEO Since 2015      
646 706-5208  www.ventrusbio.com
Small received his BS in Business from Franklin College, including participation in the Harlaxton College affiliate program in England.

Management Efficiency

The company has return on total asset (ROA) of (29.25) % which means that it has lost $29.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (74.86) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 5 records

CEO Since

Dror HaratsVascular Biogenics Ltd
2001
Jeff BaxterVBI Vaccines Inc
2009
Barry SimonNantKwest Inc
2015
Jeffrey BachaDel Mar Pharmaceuticals Inc
2017
Curtis LockshinVBI Vaccines Inc
2015

Entity Summary

Assembly Biosciences, Inc., a biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus infection and to restore health to a dysbiotic microbiome in the United States. Assembly Biosciences Inc (ASMB) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 65 people. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Center Now
   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
Hide  View All  NextLaunch Portfolio Center
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Assembly Biosciences Inc to your portfolio

Top Management

Assembly Biosciences Inc Leadership Team
Adam Zlotnick, Founder
Uri Lopatin, President, Ph.D
Myron Holubiak, Director
Lee Arnold, Executive, Ph.D
Anthony Altig, Director
Richard Colonno, Executive
William Ringo, Chairman, MBA
Richard DiMarchi, Director, Ph.D
Miguel Barbosa, Executive, Ph.D
Thomas Rollins, Executive
Mark Auerbach, Director
Derek Small, CEO
Alan Lewis, Director, Ph.D
David Barrett, COO

Stock Performance

Assembly Biosciences Performance Indicators